Literature DB >> 24043596

Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Brandie R Morgan1, Joan R Coates, Gayle C Johnson, Alyssa C Bujnak, Martin L Katz.   

Abstract

Dogs homozygous for missense mutations in the SOD1 gene develop a late-onset neuromuscular disorder called degenerative myelopathy (DM) that has many similarities to amyotrophic lateral sclerosis (ALS). Both disorders are characterized by widespread progressive declines in motor functions, accompanied by atrophic changes in the descending spinal cord tracts. Some forms of ALS are also associated with SOD1 mutations. In end-stage ALS, death usually occurs as a result of respiratory failure from severe functional impairment of respiratory muscles. The mechanisms that lead to this loss of function are not known. Dogs with DM are euthanized at all stages of disease progression, providing an opportunity to characterize the onset and progression of any pathological changes in the respiratory muscles that may precede respiratory failure. To characterize such potential disease-related pathology, we evaluated intercostal muscles from Boxer and Pembroke Welsh Corgi dogs that were euthanized at various stages of DM disease progression. DM was found to result in intercostal muscle atrophy, fibrosis, increased variability in muscle fiber size and shape, and alteration in muscle fiber type composition. This pathology was not accompanied by retraction of the motor neuron terminals from the muscle acetylcholine receptor complexes, suggesting that the muscle atrophy did not result from physical denervation. These findings provide a better understanding of the mechanisms that likely lead to respiratory failure in at least some forms of ALS and will be useful in the development and evaluation of potential therapeutic interventions using the DM model.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  SOD1; disease model; dog; morphometry; neurodegeneration

Mesh:

Substances:

Year:  2013        PMID: 24043596      PMCID: PMC4096151          DOI: 10.1002/jnr.23287

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  33 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Chronic degenerative radiculomyelopathy in the dog.

Authors:  I R Griffiths; I D Duncan
Journal:  J Small Anim Pract       Date:  1975-08       Impact factor: 1.522

3.  Degenerative myelopathy in the aging German Shepherd dog: clinical and pathologic findings.

Authors:  D R Averill
Journal:  J Am Vet Med Assoc       Date:  1973-06-15       Impact factor: 1.936

4.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Distribution of fiber types in locomotory muscles of dogs.

Authors:  R B Armstrong; C W Saubert; H J Seeherman; C R Taylor
Journal:  Am J Anat       Date:  1982-01

6.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

7.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

8.  Observations on normal skeletal muscle of mature dogs: a cytochemical, histochemical, and morphometric study.

Authors:  K G Braund; J A McGuire; C E Lincoln
Journal:  Vet Pathol       Date:  1982-11       Impact factor: 2.221

9.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

Review 10.  Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis.

Authors:  Lindsey R Fischer-Hayes; Terrell Brotherton; Jonathan D Glass
Journal:  Exp Neurol       Date:  2013-05-09       Impact factor: 5.330

View more
  8 in total

Review 1.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

2.  Electrical Impedance Myography in Dogs With Degenerative Myelopathy.

Authors:  Joseph B Kowal; Sarah A Verga; Sarbesh R Pandeya; Randall J Cochran; Julianna C Sabol; Seward B Rutkove; Joan R Coates
Journal:  Front Vet Sci       Date:  2022-05-27

3.  Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.

Authors:  Emma L Ivansson; Kate Megquier; Sergey V Kozyrev; Eva Murén; Izabella Baranowska Körberg; Ross Swofford; Michele Koltookian; Noriko Tonomura; Rong Zeng; Ana L Kolicheski; Liz Hansen; Martin L Katz; Gayle C Johnson; Gary S Johnson; Joan R Coates; Kerstin Lindblad-Toh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

4.  Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; G Diane Shelton; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-12-21       Impact factor: 4.164

5.  Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Elizabeth J Meiman; Grace Robinson Kick; Cheryl A Jensen; Joan R Coates; Martin L Katz
Journal:  Dev Neurobiol       Date:  2022-04-28       Impact factor: 3.102

6.  Changes in respiratory function in Pembroke Welsh Corgi dogs with degenerative myelopathy.

Authors:  Kanae Oyake; Yui Kobatake; Sanae Shibata; Hiroki Sakai; Miyoko Saito; Osamu Yamato; Kazuya Kushida; Sadatoshi Maeda; Hiroaki Kamishina
Journal:  J Vet Med Sci       Date:  2016-04-24       Impact factor: 1.267

7.  Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.

Authors:  C M Toedebusch; M D Bachrach; V B Garcia; G C Johnson; M L Katz; G Shaw; J R Coates; M L Garcia
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

8.  Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.

Authors:  Rebecca E H Whiting; Cheryl A Jensen; Jacqueline W Pearce; Lauren E Gillespie; Daniel E Bristow; Martin L Katz
Journal:  Exp Eye Res       Date:  2016-04-01       Impact factor: 3.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.